title: Myxomatous mitral valve disease in dogs: does size matter?
abstract: Myxomatous mitral valve disease (MMVD) is the most commonly diagnosed cardiovascular disease in the dog accounting for more than 70% of all cardiovascular disease in dogs. As are most canine diseases with genetic underpinnings, risk of MMVD is greatly increased in a subset of breeds. What is uncommon is that the vast majority of the breeds at elevated risk for MMVD are small or toy breeds with average adult weights under 9 kg. These breeds appear to have little in common other than their diminutive size. In the following review we propose a number of mechanisms by which relatively unrelated small breeds may have developed a predisposition for chronic valvular disorders. Although factors such as age are key in the expression of MMVD, taking a comprehensive look at the commonalities, as well as the differences, between the susceptible breeds may assist in finding the causal variants responsible for MMVD and translating them to improved treatments for both dogs and humans.
authors.affiliation: Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA. hgparker@mail.nih.gov
authors.forename: Heidi G
authors.initials: HG
authors.lastname: Parker
authors.forename: Paul
authors.initials: P
authors.lastname: Kilroy-Glynn
mesh_terms: D000818:Animals; D049628:Body Size; D004283:Dog Diseases / Q000473:pathology*; D004285:Dogs; D008945:Mitral Valve Prolapse / Q000473:pathology*